Last update 01 Nov 2024

Sutphin Drugs Inc

Private Company

Overview

Related

2
Drugs associated with Sutphin Drugs Inc
Fluconazole
Target
CYP51A1
Mechanism
CYP51A1 inhibitors
Active Org.
Pfizer Japan, Inc.Pfizer Japan, Inc. [+2]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
candidal vaginitis [+7]
Inactive Indication
Acquired Immunodeficiency Syndrome [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date31 Mar 1989
Dexamethasone/Tobramycin
Target
30S subunit x GR
Mechanism
30S subunit inhibitors [+1]
Active Org.
Harrow, Inc.Harrow, Inc. [+3]
Originator Org.
Novartis Pharma AG
Active Indication
Eye Infections [+3]
Inactive Indication
acute bacterial conjunctivitis [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date18 Aug 1988
4
Clinical Trials associated with Sutphin Drugs Inc
NCT04502277 / Unknown statusEarly Phase 1
Comparative,Randomized,Single-dose,2-way Crossover Bioavailability Study of 40mgm/ml 35 ml Suspension and Pfizer (Diflucan®) 40 mg/ml 35 ml Fluconazole Suspension of Participants Under Fed Condition
NCT04113772 / Unknown statusNot Applicable
Orfadin and Nitinosine Study
NCT03975205 / Unknown statusEarly Phase 1
A Bio Equivalence Study of DOXIL and Doxorubicin in Subjects With Lymphoma, Leukemia and Carcinoma
100 Clinical Results associated with Sutphin Drugs Inc
Login to view more data
0 Patents (Medical) associated with Sutphin Drugs Inc
Login to view more data
100 Deals associated with Sutphin Drugs Inc
Login to view more data
100 Translational Medicine associated with Sutphin Drugs Inc
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Dexamethasone/Tobramycin
 ( 30S subunit x GR )		Unspecified blepharoconjunctivitis
More
Pending
Fluconazole
 ( CYP51A1 )		Candidiasis
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free